<DOC>
	<DOCNO>NCT00337324</DOCNO>
	<brief_summary>We postulate frequency-modulated electromagnetic stimulation ( FREMS ) may decrease pain patient painful diabetic neuropathy .</brief_summary>
	<brief_title>Electromagnetic Stimulation ( FREMS ) Patients With Painful Diabetic Neuropathy</brief_title>
	<detailed_description>The stuy design randomize , double-blind , placebo-controlled cross-over trial . Each patient receive two series ten treatment either FREMS placebo random sequence , series last three week . Primary outcome ( daytime night-time pain score ) secondary outcome ( Motor sensory nerve conduction velocity , sensory tactile perception , foot vibration perception threshold , quality life , cutaneous microvascular flow , partial tissue tension oxygen carbon dioxide ) measure baseline , FREMS/placebo series 4 month follow-up .</detailed_description>
	<mesh_term>Peripheral Nervous System Diseases</mesh_term>
	<mesh_term>Pain</mesh_term>
	<mesh_term>Diabetic Neuropathies</mesh_term>
	<criteria>type 1 type 2 diabetes ( American Diabetes Association criterion ) painful diabetic neuropathy reduce sensory/motor nerve conduction velocity ( i.e. , &lt; 40 m/sec least one nerve trunk lower limb ) vibration perception big toe &gt; 25 V presence concomitant severe disease pregnancy renal disease ( serum creatinine &gt; 2.0 mg/dL ) history current foot ulcer lower limb arterial disease ( anklebrachial index &lt; 0.9 ) transcutaneous partial pressure oxygen &lt; 50 mmHg )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2002</verification_date>
	<keyword>Diabetic neuropathy</keyword>
	<keyword>Complications diabetes</keyword>
	<keyword>Neuropathies</keyword>
	<keyword>Electromagnetic stimulation</keyword>
	<keyword>Neuropathic pain</keyword>
</DOC>